Mehdi Hamadani, MD
@MediHumdani
BMT & Cellular Therapy | Secretary @ASTCT | Co-Chair @ASTCT CoPG | #bmtsm #CARTcell #lymsm | Personal views | Physician not Provider | 🇵🇰 🏏 🇺🇸 🏈
ID:1424156964
12-05-2013 22:40:18
7,4K Tweets
10,6K Followers
3,0K Following
Follow People
Many congrats to Dr. Mohammad Ammad Ud Din for receiving the Conquer Cancer, the ASCO Foundation Young Investigator Award this year👏👏 #ASCO24 #CLL Assoc. of Pakistani Physicians of North America Moffitt Cancer Center Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Farrukh Awan Mehdi Hamadani, MD Basil G V MD FACP FHM Hem-Onc Fellows Network MaryroseASP ASCO. Peter Kouides MD Can’t wait to see all you discover!☺️
How does #racial and #social #disparities in #CArT access affect outcomes? See below for our editorial on factors behind “race” as a barrier. 👇Race symbolizes structural barriers to timely access .. which can impact outcomes. Natalie Grover, MD . sciencedirect.com/science/articl….
Indian American Cancer Scientists awarded by SAASCR for their novel discoveries - IndiaPost NewsPaper - Congrats Mehdi Hamadani, MD! 🎉🎉🎉 indiapost.com/indian-america…
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma - congrats to my star fellow Ross Firestone for another excellent #mmsm paper Memorial Sloan Kettering Cancer Center pubmed.ncbi.nlm.nih.gov/38728378/
ASH great day on Hill w Mass and Wisconsin colleagues Mehdi Hamadani, MD Amar Kelkar, MD, MPH, FACP met with wonderful staff for @senwarren Katherine Clark Rep. Gwen Moore #fight4Hematology
With awesome ASH team on the hill to #Fight4Hematology with a focus on preventing #DrugShortages , gaining support for the #SickleCell Comprehensive Care Act (H.R. 7432) & stopping #Medicare #PhysicianPayCuts . Tammy Baldwin Elizabeth Warren MCW Cancer Center
ASH is heading to the hill tomorrow to #Fight4Hematology with a focus on preventing #DrugShortages , gaining support for the #SickleCell Comprehensive Care Act (H.R. 7432) & stopping #Medicare #PhysicianPayCuts . Follow along with us tomorrow for updates!
Barbara Pro Mehdi Hamadani, MD Andrew M. Evens, DO, MBA, MSc 'In PTCL, everything is unanswered,' added Andrew M. Evens, DO, MBA, MSc.
'I proudly call myself a reluctant transplanter for T-cell lymphomas in remission,' said Mehdi Hamadani, MD.
#HOPLive24 buff.ly/3xNw3wF
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival Marcelo Pasquini MCW Cancer Center pubmed.ncbi.nlm.nih.gov/38701390/
Myeloma controversies #HOPLive24 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Vincent Rajkumar Joseph Mikhael Aaron Goodman - “Papa Heme” Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽
Great point ‘we want to do good by our pts” so many nuances that a tweet can’t capture
The Giant in Oncology Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 presenting “Unanswered Questions” in Bispecifics with Aaron Goodman - “Papa Heme” & Dr. Bishop as panelists.
#HOPLive24 right here in Chicago.
Naveen Pemmaraju, MD Vincent Rajkumar Sanam Loghavi, MD صنم لغوی 🔬🧬 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Joseph Mikhael Mikkael A. Sekeres MD, MS Mehdi Hamadani, MD Alan Skarbnik
CAR T-cell Therapy in Mantle cell with sCNS Involvement.
Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance?
Mazyar Shadman, MD MPH Gulrayz Ahmed Farrukh Awan Tim Fenske Madiha Iqbal MD Mohamed Kharfan-Dabaja, MD, MBA MCW Cancer Center #lymsm #CART
ashpublications.org/bloodadvances/…
Flying home after a spectacular ASTCT leadership course. One of the many enlightening moments was a series of talks and panel discussion about leadership challenges by three hematology and cell therapy masters, Mary Horowitz, Brian J. Bolwell, MD and Fred LeMaistre Sarah Cannon Docs.